Showing results (71-80 of 263) with videos related to
Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|January 1, 1992
Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic dataA van der Gaast, P Sonneveld, D R Mans, et al.Seminars in Oncology|April 1, 1992
Absolute bioavailability and pharmacokinetics of oral teniposideT A Splinter, J J Holthuis, T C Kok, et al.The Journal of Urology|April 1, 1991
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratomaA van der Gaast, J W Hoekstra, J J Croles, et al.British Journal of Haematology|September 1, 1994
Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumourL T Vlasveld, T A Splinter, A Hagemeijer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Overexpression of cyclin D1 is associated with metastatic prostate cancer to boneM Drobnjak, I Osman, H I Scher, et al.Anticancer Research|July 1, 1985
Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breastC N Sternberg, A Yagoda, E Casper, et al.Investigational New Drugs|January 1, 1986
Phase II trial of 10 deaza-aminopterin in patients with bladder cancerT Ahmed, A Yagoda, H I Scher, et al.Cancer|October 15, 1991
Sarcoid-like lymphadenopathy mimicking metastatic testicular cancerT C Kok, J G Haasjes, T A Splinter, et al.Anticancer Research|November 1, 1984
Phase II trial of 10-deazaaminopterin for advanced hypernephromaH I Scher, A Yagoda, T Ahmed, et al.Oncology (Williston Park, N.Y.)|October 23, 1997
Combined-modality therapy for bladder cancerJ A McCaffrey, D F Bajorin, H I Scher, et al.Pageof 27